<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00315107</url>
  </required_header>
  <id_info>
    <org_study_id>HND01</org_study_id>
    <nct_id>NCT00315107</nct_id>
  </id_info>
  <brief_title>Estrogen Treatment in Acromegalic Women</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Montréal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Université de Montréal</source>
  <brief_summary>
    <textblock>
      Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients
      with resistance to somatostatin analogs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a canadian multicenter study with a randomized, double-blind, placebo-controlled
      design, to assess the efficacy and safety of adjuvant alesse in female acromegalic patients
      with suboptimal response to sandostatin LAR treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2006</start_date>
  <completion_date>August 2007</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>30</enrollment>
  <condition>Acromegaly</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alesse</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women 18 years and older treated with somatostatin analogs

          -  Active acromegaly

        Exclusion Criteria:

          -  Cardiovascular or cerebrovascular disease

          -  Thrombophlebitis or thromboembolism

          -  Breast cancer

          -  Non-controlled arterial hypertension

          -  Smoking

          -  Pregnancy or lactation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omar Serri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHUM- Endocrinology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Omar SERRI, MD</last_name>
    <phone>514-890-8000</phone>
    <phone_ext>25607</phone_ext>
    <email>omar.serri@umontreal.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHUM - Notre-Dame Hospital</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2L 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Omar Serri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2006</study_first_submitted>
  <study_first_submitted_qc>April 13, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2006</study_first_posted>
  <last_update_submitted>May 25, 2006</last_update_submitted>
  <last_update_submitted_qc>May 25, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 26, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acromegaly</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

